BEAM
Price
$22.03
Change
+$0.57 (+2.66%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
2.16B
33 days until earnings call
ENTA
Price
$6.95
Change
-$0.18 (-2.52%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
152.42M
32 days until earnings call
Interact to see
Advertisement

BEAM vs ENTA

Header iconBEAM vs ENTA Comparison
Open Charts BEAM vs ENTABanner chart's image
Beam Therapeutics
Price$22.03
Change+$0.57 (+2.66%)
Volume$36.06K
Capitalization2.16B
Enanta Pharmaceuticals
Price$6.95
Change-$0.18 (-2.52%)
Volume$1.4K
Capitalization152.42M
BEAM vs ENTA Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. ENTA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and ENTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BEAM: $21.46 vs. ENTA: $7.13)
Brand notoriety: BEAM and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 196% vs. ENTA: 164%
Market capitalization -- BEAM: $2.16B vs. ENTA: $152.42M
BEAM [@Biotechnology] is valued at $2.16B. ENTA’s [@Biotechnology] market capitalization is $152.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, ENTA is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while ENTA’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 4 bearish.
  • ENTA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ENTA.

Price Growth

BEAM (@Biotechnology) experienced а +7.95% price change this week, while ENTA (@Biotechnology) price change was -10.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

ENTA is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.16B) has a higher market cap than ENTA($152M). ENTA YTD gains are higher at: 24.000 vs. BEAM (-13.468). ENTA has higher annual earnings (EBITDA): -87.12M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. ENTA (193M). ENTA has less debt than BEAM: ENTA (58.7M) vs BEAM (158M). ENTA (64.5M) and BEAM (63.6M) have equivalent revenues.
BEAMENTABEAM / ENTA
Capitalization2.16B152M1,420%
EBITDA-399.03M-87.12M458%
Gain YTD-13.46824.000-56%
P/E RatioN/AN/A-
Revenue63.6M64.5M99%
Total Cash1.22B193M632%
Total Debt158M58.7M269%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMENTA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WAEMX2.87N/A
N/A
Wasatch Emerging Markets Small Cap Inv
SBLGX64.29N/A
N/A
ClearBridge Large Cap Growth A
DDVRX13.99N/A
N/A
Macquarie Value R
SEWIX17.09N/A
N/A
NAA World Equity Income Instl
PIGWX16.25N/A
N/A
Putnam International Value R6

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+5.71%
CRSP - BEAM
72%
Closely correlated
+9.60%
NTLA - BEAM
65%
Loosely correlated
+9.08%
RXRX - BEAM
64%
Loosely correlated
+4.29%
SYRE - BEAM
59%
Loosely correlated
+6.02%
ABSI - BEAM
58%
Loosely correlated
+7.20%
More